Evidence map›Paper›PMID 39289638›Full record

ArticleBMC neurology2024

Early-onset phenotype in a patient with an intermediate allele and a large SCA1 expansion: a case report.

Guillaume Baille, Nicolas Geoffre, Anna Wissocq, Pauline Planté-Bordeneuve, Eugénie Mutez, Vincent Huin

Abstract readCase Reports
In one paragraph

Article in BMC neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guillaume BailleDelafontaine Hospital Center, Department of Neurology, Saint-Denis, F93200, France.ORCID http://orcid.org/0000-0002-0248-5772
Nicolas GeoffreDepartment of Toxicology and Genopathies, UF Neurobiology, CHU Lille, Lille, F-59000, France.ORCID http://orcid.org/0009-0002-4569-2015
Anna WissocqDepartment of Toxicology and Genopathies, UF Neurobiology, CHU Lille, Lille, F-59000, France.ORCID http://orcid.org/0009-0004-8942-9811
Pauline Planté-BordeneuveDepartment of Toxicology and Genopathies, UF Neurobiology, CHU Lille, Lille, F-59000, France.
Eugénie MutezDepartment of Neurology and Movement disorders, CHU Lille, Lille, F-59000, France.ORCID http://orcid.org/0000-0002-5947-0432
Vincent HuinDepartment of Toxicology and Genopathies, UF Neurobiology, CHU Lille, Lille, F-59000, France. vincent.huin@inserm.fr.ORCID http://orcid.org/0000-0001-8201-5406

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSpinocerebellar ataxia type 1, is a rare neurodegenerative disorder with autosomal dominant inheritance belonging to the polyglutamine diseases. The diagnosis of this disease requires genetic testing that may also include the search for CAT interruption of the CAG repeat tract. CASE PRESENTATION: One 23-years-old patient suffers from a severe ataxia, with early-onset and rapid progression of the disease. His father might have been affected, but no molecular confirmation has been performed. The genetic results were negative for the Friedreich's ataxia, spinocerebellar ataxia type 2, 3, 6, 7 and 17. The numbers of CAG repeats in the ATXN1 gene was assessed by fluorescent PCR, tripled-primed PCR and enzymatic digestion for the search of sequence interruption in the CAG repeats. The patient carried one pathogenic allele of 61 CAG and one intermediate allele of 37 CAG in the ATXN1 gene. Both alleles were uninterrupted.

conclusionsWe report a rare case of spinocerebellar ataxia type 1 with an intermediate allele and a large SCA1 expansion. The determination of the absence of CAT interruption brought crucial information concerning this molecular diagnosis, the prediction of the disease and had practical consequences for genetic counseling.

Indexed as

Ataxin-1PhenotypeSpinocerebellar AtaxiasAge of OnsetAllelesAtaxinsHumansMaleNerve Tissue ProteinsTrinucleotide Repeat ExpansionYoung AdultAtaxin-1AtaxinsATXN1 protein, humanNerve Tissue ProteinsCase reportCerebellar ataxiaDNA repeat expansionPhenotypePolyglutamine diseaseSCA1Spinocerebellar degenerations

Identifiers

PMID39289638
PMCPMC11406724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.